Susquehanna International Group, LLP Galectin Therapeutics Inc Transaction History

Susquehanna International Group, LLP

  • $823 Billion
  • Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 446,578 shares of GALT stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
446,578
Previous 193,200 131.15%
Holding current value
$2.46 Million
Previous $407,000 358.48%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$2.09 - $5.37 $529,560 - $1.36 Million
253,378 Added 131.15%
446,578 $1.87 Million
Q2 2025

Aug 14, 2025
BUY
$1.25 - $3.29 $227,318 - $598,302
181,855 Added 1602.95%
193,200 $407,000
Q1 2025

May 14, 2025
BUY
$1.1 - $1.76 $1,201 - $1,921
1,092 Added 10.65%
11,345 $13,000
Q4 2024

Feb 14, 2025
SELL
$0.87 - $3.0 $61,956 - $213,642
-71,214 Reduced 87.41%
10,253 $12,000
Q3 2024

Nov 14, 2024
SELL
$2.04 - $2.86 $246,570 - $345,682
-120,868 Reduced 59.74%
81,467 $224,000
Q2 2024

Aug 15, 2024
SELL
$2.13 - $4.2 $335,519 - $661,588
-157,521 Reduced 43.77%
202,335 $457,000
Q1 2024

May 07, 2024
BUY
$1.6 - $2.44 $449,177 - $684,995
280,736 Added 354.82%
359,856 $860,000
Q4 2023

Feb 14, 2024
BUY
$1.6 - $2.18 $77,043 - $104,971
48,152 Added 155.49%
79,120 $131,000
Q3 2023

Nov 14, 2023
BUY
$1.38 - $1.97 $7,842 - $11,195
5,683 Added 22.48%
30,968 $59,000
Q2 2023

Aug 11, 2023
SELL
$1.32 - $2.08 $6,658 - $10,491
-5,044 Reduced 16.63%
25,285 $36,000
Q1 2023

May 16, 2023
SELL
$1.1 - $2.4 $18,566 - $40,509
-16,879 Reduced 35.75%
30,329 $63,000
Q4 2022

Feb 14, 2023
BUY
$1.03 - $1.66 $30,511 - $49,174
29,623 Added 168.46%
47,208 $53,000
Q3 2022

Nov 14, 2022
SELL
$1.31 - $2.48 $19,312 - $36,560
-14,742 Reduced 45.6%
17,585 $29,000
Q2 2022

Aug 15, 2022
SELL
$1.19 - $1.74 $57,278 - $83,751
-48,133 Reduced 59.82%
32,327 $42,000
Q1 2022

May 16, 2022
SELL
$1.61 - $2.31 $143,442 - $205,809
-89,095 Reduced 52.55%
80,460 $130,000
Q4 2021

Feb 14, 2022
BUY
$2.07 - $3.8 $143,316 - $263,093
69,235 Added 69.01%
169,555 $351,000
Q3 2021

Nov 15, 2021
SELL
$2.59 - $4.15 $91,142 - $146,038
-35,190 Reduced 25.97%
100,320 $389,000
Q2 2021

Aug 11, 2021
BUY
$2.07 - $5.1 $133,127 - $327,996
64,313 Added 90.33%
135,510 $434,000
Q1 2021

May 17, 2021
SELL
$1.96 - $2.57 $90,840 - $119,111
-46,347 Reduced 39.43%
71,197 $154,000
Q4 2020

Feb 16, 2021
SELL
$2.24 - $2.87 $27,247 - $34,910
-12,164 Reduced 9.38%
117,544 $263,000
Q3 2020

Nov 16, 2020
BUY
$2.53 - $3.64 $12,566 - $18,079
4,967 Added 3.98%
129,708 $347,000
Q2 2020

Aug 14, 2020
BUY
$1.66 - $3.15 $16,425 - $31,169
9,895 Added 8.62%
124,741 $382,000
Q1 2020

May 15, 2020
SELL
$1.51 - $3.0 $75,999 - $150,993
-50,331 Reduced 30.47%
114,846 $225,000
Q4 2019

Feb 14, 2020
SELL
$2.79 - $4.32 $84,492 - $130,826
-30,284 Reduced 15.49%
165,177 $472,000
Q3 2019

Nov 14, 2019
SELL
$3.0 - $4.05 $502,041 - $677,755
-167,347 Reduced 46.13%
195,461 $717,000
Q2 2019

Aug 16, 2019
BUY
$3.61 - $5.0 $9,732 - $13,480
2,696 Added 0.75%
362,808 $1.51 Million
Q2 2019

Aug 14, 2019
SELL
$3.61 - $5.0 $304,889 - $422,285
-84,457 Reduced 19.0%
360,112 $1.49 Million
Q1 2019

May 15, 2019
BUY
$3.86 - $6.02 $1.09 Million - $1.69 Million
281,460 Added 172.56%
444,569 $2.27 Million
Q4 2018

Feb 14, 2019
SELL
$3.43 - $5.74 $991,952 - $1.66 Million
-289,199 Reduced 63.94%
163,109 $559,000
Q3 2018

Nov 14, 2018
BUY
$3.68 - $6.93 $347,815 - $654,988
94,515 Added 26.42%
452,308 $2.72 Million
Q2 2018

Aug 14, 2018
BUY
$3.16 - $9.16 $961,676 - $2.79 Million
304,328 Added 569.21%
357,793 $2.28 Million
Q1 2018

May 15, 2018
SELL
$3.78 - $5.97 $62,407 - $98,564
-16,510 Reduced 23.59%
53,465 $253,000
Q4 2017

Feb 14, 2018
SELL
$1.54 - $3.34 $151,956 - $329,567
-98,673 Reduced 58.51%
69,975 $234,000
Q3 2017

Nov 14, 2017
BUY
$1.67 - $2.3 $281,642 - $387,890
168,648
168,648 $358,000

Others Institutions Holding GALT

# of Institutions
93
Shares Held
11.1M
Call Options Held
142K
Put Options Held
81.4K
View Full List

About GALECTIN THERAPEUTICS INC

GALT Quotes by TradingView
  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $327M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email